HAS-BLED Bleeding Risk Score
Score HAS-BLED to assess anticoagulation bleeding risk in AF
Embed HAS-BLED Bleeding Risk Score ▾
Add this tool to your website or blog for free. Includes a small "Powered by ToolWard" bar. Pro users can remove branding.
<iframe src="https://toolward.com/tool/has-bled-bleeding-risk-score?embed=1" width="100%" height="500" frameborder="0" style="border:1px solid #e2e8f0;border-radius:12px"></iframe>
Community Tips 0 ▾
No tips yet. Be the first to share!
Compare with similar tools ▾
| Tool Name | Rating | Reviews | AI | Category |
|---|---|---|---|---|
| HAS-BLED Bleeding Risk Score Current | 4.1 | 1419 | - | Medical Diagnostics Reference |
| ECG Heart Rate Calculator | 4.6 | 2136 | - | Medical Diagnostics Reference |
| Neonatal Gestational Age | 4.6 | 2260 | - | Medical Diagnostics Reference |
| Peak Flow Percentage Predicted | 4.8 | 1610 | - | Medical Diagnostics Reference |
| Glasgow Coma Scale Calculator | 4.0 | 2816 | - | Medical Diagnostics Reference |
| CURB-65 Pneumonia Severity Score | 4.4 | 3100 | - | Medical Diagnostics Reference |
About HAS-BLED Bleeding Risk Score
Assess Bleeding Risk During Anticoagulation Therapy
Anticoagulation saves lives by preventing strokes in atrial fibrillation and treating venous thromboembolism, but it comes with an inherent risk of bleeding. The HAS-BLED Bleeding Risk Score calculator quantifies this risk using nine clinical parameters, helping clinicians balance the benefits of anticoagulation against the potential for major bleeding complications. It is the most widely recommended bleeding risk assessment tool in international AF guidelines.
A common misconception is that a high HAS-BLED score means anticoagulation should be stopped. In reality, it means the patient needs closer monitoring and attention to modifiable risk factors. Almost every patient with a high stroke risk also has a high bleeding risk because many risk factors overlap. This tool helps clinicians identify which bleeding risks can be modified to make anticoagulation safer.
How to Calculate the HAS-BLED Score
Each parameter scores 1 point for a maximum of 9. H - Hypertension (uncontrolled, systolic over 160 mmHg). A - Abnormal renal and/or liver function (1 point each, maximum 2). S - Stroke history. B - Bleeding history or predisposition. L - Labile INR (time in therapeutic range under 60%, applicable to warfarin patients). E - Elderly (age over 65). D - Drugs or alcohol (antiplatelet agents, NSAIDs, or alcohol excess; 1 point each, maximum 2).
The tool calculates the total score and classifies bleeding risk as low (0-1), moderate (2), or high (3 or more). It highlights which of the patient's risk factors are potentially modifiable - a crucial distinction that guides clinical action.
Who Uses HAS-BLED?
Every clinician prescribing anticoagulation should calculate HAS-BLED alongside the stroke risk score. Cardiologists and general practitioners managing atrial fibrillation calculate it routinely. Haematologists overseeing anticoagulation clinics use it to risk-stratify patients for monitoring intensity. Pharmacists conducting medication reviews flag patients with high HAS-BLED scores for clinical review.
The HAS-BLED Bleeding Risk Score calculator is particularly valuable in multidisciplinary team meetings where anticoagulation decisions are discussed collaboratively, providing a standardised framework for the discussion.
Modifiable vs Non-Modifiable Risk Factors
This is where HAS-BLED's real clinical value lies. Uncontrolled hypertension can be treated more aggressively. Labile INR can be addressed by switching to a direct oral anticoagulant. Concomitant antiplatelet or NSAID use can be reviewed and potentially discontinued. Alcohol excess can be counselled. By addressing these modifiable factors, the overall bleeding risk decreases even though the HAS-BLED score components remain.
Practical Guidance
Calculate HAS-BLED at the time of anticoagulation initiation and reassess at least annually. A score of 3 or more should trigger a review of modifiable risk factors, not automatic cessation of anticoagulation. Document the score and the actions taken to mitigate bleeding risk. When comparing stroke risk (CHA2DS2-VASc) versus bleeding risk (HAS-BLED), the net clinical benefit of anticoagulation almost always favours treatment when the stroke risk score is 2 or more - the key is to anticoagulate safely by minimising controllable bleeding risks.